The diagnostic and prognostic value of soluble ST2 in Sepsis

被引:0
|
作者
Ye, Xinghua [1 ]
Wang, Jia [1 ]
Hu, Le [1 ]
Zhang, Ying [1 ]
Li, Yixuan [1 ]
Xuan, Jingchao [1 ]
Han, Silu [1 ]
Qu, Yifan [1 ]
Yang, Long [1 ]
Yang, Jun [1 ]
Wang, Junyu [1 ]
Wei, Bing [1 ]
机构
[1] Capital Med Univ, Beijing Chao Yang Hosp, Emergency Med Clin Res Ctr, Beijing Key Lab Cardiopulm Cerebral Resuscitat, Beijing, Peoples R China
关键词
APACHE II score; diagnosis; lactic acid; prognosis; Sepsis; SOFA score; soluble ST2; SEPTIC SHOCK; THERAPY;
D O I
10.3389/fmed.2024.1487443
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine the diagnostic and prognostic value of soluble suppression of tumorigenicity 2 (sST2) in patients with sepsis. Methods A total of 113 critically ill patients were enrolled at the emergency department of Beijing Chaoyang Hospital Jing Xi Branch. Venous blood levels of sST2 were measured using the AFIAS-6 dry fluorescence immunoassay analyzer. Based on Sepsis 3.0 criteria, patients were categorized into a sepsis group (76 cases) and a non-sepsis group (37 cases). The sepsis group was further divided into non-survivors (38 cases) and survivors (38 cases) based on 28-day survival outcomes. The vital signs, blood gas analysis, routine blood tests, liver and kidney function tests, procalcitonin (PCT), C-reactive protein (CRP), sST2, left ventricular ejection fraction (LVEF), and other basic characteristics of the patients were recorded. Further, the SOFA, qSOFA and APACHE II scores of each patient were calculated. Statistical analysis was performed using SPSS 25.0, including logistic regression and ROC curve analysis to assess prognostic factors. Results The serum sST2 levels in the sepsis group (125.00 +/- 60.32 ng/mL) were significantly higher than in the non-sepsis group (58.55 +/- 39.03 ng/mL) (p < 0.05). The SOFA score (8.08 +/- 2.88), APACHE II score (18.00 +/- 4.72), blood sST2 levels (168.06 +/- 36.75 ng/mL) and lactic acid levels (2.89 +/- 3.28) in the non-survivor group were significantly higher than the survivor group (p < 0.05). Multiple logistic regression analysis showed that sST2, SOFA score, APACHE II score and lactic acid levels were independent risk factors for poor prognosis in patients with sepsis. The ROC curve analysis of the above indexes showed no significant differences between the AUC of sST2 (0.912) and the SOFA score (0.929) (z = 0.389, p = 0.697), or the APACHE II score (0.933) (z = 0.484, p = 0.627). However, there was a significant difference between the AUC of sST2 (0.912) and lactic acid levels (0.768) (z = 2.153, p = 0.030). Conclusion Blood levels of sST2 show a clinically diagnostic and prognostic value in sepsis. Further, sST2 shows a similar predictive ability as the SOFA and APACHE II scores in determining the prognosis of sepsis patients. However, sST2 has a higher predictive ability than lactic acid levels in determining prognosis in sepsis.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure
    Mueller, Thomas
    Gegenhuber, Alfons
    Leitner, Isabella
    Poelz, Werner
    Haltmayer, Meinhard
    Dieplinger, Benjamin
    CLINICA CHIMICA ACTA, 2016, 463 : 158 - 164
  • [22] Diagnostic and prognostic values of serum Selenoprotein P and soluble St2 levels in pulmonary embolism
    Boyraci, Neslihan
    Onur, Seda Tural
    Kara, Kaan
    Akyil, Fatma Tokgoz
    Abali, Hulya
    Kocaoglu, Asli
    Sokucu, Sinem Nedime
    Altin, Sedat
    Pehlivan, Sacide
    Oyaci, Yasemin
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 368 (05): : 438 - 445
  • [23] Prognostic additive value of high sensitivity soluble ST2 in ambulatory heart failure patients
    Bayes-Genis, A.
    De Antonio, M.
    Galan, A.
    Urrutia, A.
    Cabanes, R.
    Cano, L.
    Gonzalez, B.
    Diez, C.
    Pascual, T.
    Lupon, J.
    EUROPEAN HEART JOURNAL, 2011, 32 : 19 - 20
  • [24] Prognostic value of soluble ST2 biomarker in heart failure patients with preserved ejection fraction
    Kopeva, K. V.
    Teplyakov, A. T.
    Grakova, E. V.
    Ogurkova, O. N.
    Soldatenko, M. V.
    EUROPEAN HEART JOURNAL, 2018, 39 : 784 - 784
  • [25] Prognostic value of soluble ST2 in unselected cardiac patients admitted to the intensive care unit
    Dieplinger, B.
    Egger, M.
    Koehler, W.
    Firlinger, F.
    Poelz, W.
    Hengst, L.
    Lenz, K.
    Haltmayer, M.
    Mueller, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 730 - 730
  • [26] Prognostic value of soluble ST2 in unselected cardiac patients admitted to the intensive care unit
    Dieplinger, B.
    Egger, M.
    Koehler, W.
    Firlinger, F.
    Poelz, W.
    Hengst, L.
    Lenz, K.
    Haltmayer, M.
    Mueller, T.
    EUROPEAN HEART JOURNAL, 2011, 32 : 730 - 730
  • [27] PROGNOSTIC VALUE OF ST2 AFTER MYOCARDIAL INFARCTION
    Jenkins, William
    Jaffe, Allan
    Roger, Veronique
    Weston, Susan
    AbouEzzeddine, Omar
    Manemann, Sheila M.
    Sarano, Maurice
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 439 - 439
  • [28] Soluble ST2: a valuable prognostic marker in heart failure
    Sugeevan Savarimuthu
    Pavan Goel
    Amer Harky
    Heart Failure Reviews, 2022, 27 : 2155 - 2164
  • [29] Soluble ST2: A Novel Prognostic Biomarker of Heart Failure
    Tung, Ying-Chang
    Chu, Pao-Hsien
    ACTA CARDIOLOGICA SINICA, 2014, 30 (05) : 501 - 503
  • [30] Soluble ST2: a valuable prognostic marker in heart failure
    Savarimuthu, Sugeevan
    Goel, Pavan
    Harky, Amer
    HEART FAILURE REVIEWS, 2022, 27 (06) : 2155 - 2164